Boyce Sarah Insider Trades

Insider Trading History

Track insider trading activity for Boyce Sarah. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $3.92M 305,871 shares
Last Trade
Sep 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.5M 50,000 shares
$49.95
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $13.1M 1,022,015 shares
Last Trade
Sep 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.52M 50,000 shares
$50.36
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $4.56M 355,871 shares
Last Trade
Sep 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.52M 50,000 shares
$50.36
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $13.7M 1,072,015 shares
Last Trade
Aug 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.21M 25,000 shares
$48.58
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $3.92M 305,871 shares
Last Trade
Aug 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.23M 25,000 shares
$49.39
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $4.24M 330,871 shares
Last Trade
Aug 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.21M 25,000 shares
$48.58
$12.81
Contineum Therapeutics
Contineum Therapeutics CTNM
Director
Holding Value $176k 14,750 shares
Last Trade
Jun 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.1k 14,750 shares
$4.01
$11.91
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $3.92M 305,871 shares
Last Trade
Mar 20, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$980k 31,540 shares
$31.06
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $4.39M 343,070 shares
Last Trade
Jan 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$297k 10,397 shares
$28.59
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $4.46M 347,808 shares
Last Trade
Jan 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.18M 165,000 shares
$31.42
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $3.4M 265,308 shares
Last Trade
Dec 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.04M 31,855 shares
$32.66
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $5.91M 461,015 shares
Last Trade
Aug 06, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.23M 28,000 shares
$43.81
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $2.63M 205,043 shares
Last Trade
Aug 06, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.21M 28,000 shares
$43.35
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $2.99M 233,043 shares
Last Trade
Aug 06, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.23M 28,000 shares
$43.81
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $2.99M 233,043 shares
Last Trade
Jul 09, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.13M 28,000 shares
$40.37
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $2.63M 205,043 shares
Last Trade
Jul 09, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.12M 28,000 shares
$39.93
$12.81
Avidity Biosciences
Avidity Biosciences RNA
President And CEO
Holding Value $6.26M 489,015 shares
Last Trade
Jul 09, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.13M 28,000 shares
$40.37
$12.81
OmniAb
OmniAb AHPA
Director
Holding Value $245k 40,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 40,000 shares
$6.12
$6.12
OmniAb- Warrants (01/11/2027)
OmniAb- Warrants (01/11/2027) AHPAW
Director
Holding Value $27.7k 40,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14k 40,000 shares
$0.35
$0.69
OmniAb- Units (1 Ord Share Class A & 1/3 War)
OmniAb- Units (1 Ord Share Class A & 1/3 War) AHPAU
Director
Holding Value $246k 40,000 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$246k 40,000 shares
$6.16
$6.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up